B4GALT6 Gene: Beta-1,4-Galactosyltransferase 6

Key enzyme in glycosphingolipid biosynthesis and laminin assembly

Gene Information Card

Symbol B4GALT6
Full Name Beta-1,4-Galactosyltransferase 6
Gene Type Protein coding
Chromosomal Location 18q11.2
NCBI Gene ID 9331 ncbi.nlm.nih.gov/gene/9331
Ensembl ID ENSG00000101445
UniProt ID Q9UBX8
OMIM ID 604017
HGNC ID HGNC:928
Aliases B4Gal-T6, beta4Gal-T6, GalT6, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase 6

Description

B4GALT6 encodes beta-1,4-galactosyltransferase 6, a type II membrane-bound glycosyltransferase that catalyzes the transfer of galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) in a beta-1,4 linkage. This enzyme is essential for the biosynthesis of glycosphingolipids (e.g., lactosylceramide) and for the assembly of laminin-332 (laminin-5) in basement membranes. Mutations in B4GALT6 cause autosomal recessive spastic paraplegia type 26 (SPG26) and congenital disorder of glycosylation type IId (CDG-IId).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Spastic paraplegia 26 (SPG26) Loss-of-function mutations impair glycosphingolipid synthesis in neurons, leading to axonal degeneration Multiple families; homozygous/compound heterozygous missense and nonsense variants (PMID: 23332916)
Congenital disorder of glycosylation type IId (CDG-IId) Defective beta-1,4-galactosylation of N-glycans and glycosphingolipids causes multisystem developmental abnormalities Case reports; biallelic mutations (PMID: 23332916)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 6.1 Low
Kidney 9.7 Low
Testis 15.2 Medium
Placenta 11.4 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 18.5 High expression
HeLa 14.2 Medium expression
K562 9.8 Low expression
SH-SY5Y 22.1 High expression (neuronal)
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.680G>A (p.Arg227Gln) Missense Rare Loss of galactosyltransferase activity; associated with SPG26
c.1A>G (p.Met1Val) Start loss Rare Complete loss of protein; associated with CDG-IId
c.907C>T (p.Arg303*) Nonsense Rare Truncated protein; loss of function; SPG26
c.1123G>A (p.Gly375Arg) Missense Rare Reduced enzyme activity; SPG26
Mutation functional classification

Loss of Function (LOF)

Most B4GALT6 mutations are loss-of-function, reducing or abolishing galactosyltransferase activity, leading to glycosphingolipid deficiency and laminin misassembly.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported; inheritance is autosomal recessive.

Pathways

Glycosphingolipid biosynthesis - lacto and neolacto series (KEGG: hsa00601)
N-Glycan biosynthesis (KEGG: hsa00510)
Laminin interactions (Reactome: R-HSA-3000157)

Protein Summary

Beta-1,4-galactosyltransferase 6 is a 344-amino acid type II transmembrane protein localized to the Golgi apparatus. It contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain facing the Golgi lumen. The enzyme transfers galactose to GlcNAc in beta-1,4 linkage, producing lactosylceramide (key for glycosphingolipid synthesis) and modifying laminin-332. Loss of function leads to accumulation of glucosylceramide and defective laminin assembly, underlying neurological and developmental disorders.

Related Products

Product name Cat.No. Species Gene ID
B4GALT6 Knockout HEK293 Cell Line EDJ-KQ6549 Human 9331 Details Get a Quote
B4GALT6 Knockout A-549 Cell Line EDJ-KQ30743 Human 9331 Details Get a Quote
B4GALT6 Knockout HCT 116 Cell Line EDJ-KQ30744 Human 9331 Details Get a Quote
B4GALT6 Knockout HeLa Cell Line EDJ-KQ55129 Human 9331 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: